WCN24-395 AVACOPAN IN MPO-ANCA VASCULITIS: WHEN CORTICOSTEROIDS CAN NOT BE THE LONG TERM ANSWER

WCN24-395 AVACOPAN IN MPO-ANCA VASCULITIS: WHEN CORTICOSTEROIDS CAN NOT BE THE LONG TERM ANSWER

Saved in:

Bibliographic Details
Main Authors:	Sofia Sousa, Ana Cunha, Beatriz Gil Braga, José Silvano, Sofia Correia, Andreia Campos, Josefina Santos
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S246802492400370X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
by: van Leeuwen JR, et al.
Published: (2025-01-01)

Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort
by: Yasuhiro Katsumata, et al.
Published: (2025-01-01)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

WCN25-2856 OVERLAP SYNDROME: A RARE TRIPLE-POSITIVE SYSTEMIC VASCULITIS: ANCA (MPO, PR3) AND ANTI-MBG
by: NEHED GHENAM, et al.
Published: (2025-02-01)

A Case Report Describing a Rare Presentation of Simultaneous Occurrence of MPO-ANCA-Associated Vasculitis and Rheumatoid Arthritis
by: Nathalie Foray, et al.
Published: (2016-01-01)

Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
by: Reza Zonozi, et al.
Published: (2024-06-01)

Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies–Associated Vasculitis in a Real-World Setting
by: Jonas Zimmermann, et al.
Published: (2024-09-01)

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
by: Ulrich Specks, et al.
Published: (2025-01-01)

WCN24-2308 WHAT TO EXPECT WHEN DIAGNOSING ANCA-ASSOCIATED VASCULITIS? A PORTUGUESE CENTER PERSPECTIVE AND EXPERIENCE
by: António Inácio, et al.
Published: (2024-04-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

WCN25-1069 WHEN THE ANSWER IS IN THE URINARY SEDIMENT
by: Beatriz Mendes, et al.
Published: (2025-02-01)

A Case of Diffuse Alveolar Hemorrhage Associated with High-Titer of MPO-ANCA Demonstrating Cytoplasmic Staining Pattern
by: Jihad Ben Gabr, et al.
Published: (2019-01-01)

WCN25-4130 CLINICAL PRESENTATION OF THE FAMILIAL CASES OF ANCA-ASSOCIATED VASCULITIS: A SYSTEMATIC REVIEW
by: Nikolay Bulanov, et al.
Published: (2025-02-01)

Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Combined Data From Three Clinical Trials
by: Peter A. Merkel, et al.
Published: (2025-04-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
by: Atulya Aman Khosla, et al.
Published: (2023-01-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

Burden of coronary artery calcification in ANCA-associated vasculitis
by: Claire Cook, et al.
Published: (2025-01-01)

Disease Activity and Tendency to Relapse in ANCA-Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies
by: Sofia Smargianaki, et al.
Published: (2024-01-01)

WCN24-283 CAN SERUM AND HISTOLOGIC BIOMARKERS PREDICT KIDNEY AND OVERALL SURVIVAL IN ANCA-ASSOCIATED VASCULITIS?
by: António Inácio, et al.
Published: (2024-04-01)

WCN24-974 P-ANCA VASCULITIS VS. LUPUS NEPHRITIS A POSSIBLE COEXISTENCE? CASE REPORT
by: Karen Kortright, et al.
Published: (2024-04-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

Impact of Early MPO-ANCA Positivity on Unique Clinical Features in Korean Patients with EGPA: A Single-Centre Cohort Study
by: Oh Chan Kwon, et al.
Published: (2025-06-01)

MPO-ANCA-Associated Hypertrophic Pachymeningitis Mimicking IgG4-Related Disease: A Case Report and Literature Review
by: Chen Y, et al.
Published: (2025-05-01)

WCN24-1407 CLINICAL PANORAMA OF ANCA ASSOCIATED VASCULITIS IN A RURAL LOW-INCOME POPULATION OF LATIN AMERICA
by: PAULA VIOLETA RODRIGUEZ SEGURA, et al.
Published: (2024-04-01)

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination
by: Shiko Gen, et al.
Published: (2023-01-01)

Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective
by: Hannah L. Stacey, et al.
Published: (2024-12-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

Overlap Syndrome in Late-Onset Systemic Lupus Erythematosus With Lupus Nephritis and MPO-ANCA Pauci-Immune Glomerulonephritis and Tuberculosis: An Uncommon Association
by: Jaime Arturo Dulce Muñoz, et al.
Published: (2025-01-01)

Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis
by: Evelina Elmér, et al.
Published: (2020-01-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

ANCA Vasculitis and Hemophagocytic Lymphohistiocytosis following a Fecal Microbiota Transplant
by: Adam Amlani, et al.
Published: (2018-01-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)